Legend Biotech
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $186,522 | $160,205 | $186,523 | $93,991 |
Gross Profit | 112,600 | 104,736 | 136,072 | 33,530 |
EBITDA | 52,459 | -109,910 | -7,117 | -48,591 |
EBIT | 45,663 | -115,382 | -12,486 | -54,313 |
Net Income | 26,284 | -125,321 | -18,196 | -59,793 |
Net Change In Cash | 186,522 | 160,205 | 186,523 | 93,991 |
Free Cash Flow | -84,456 | -77,887 | -5,068 | -6,605 |
Cash | 286,749 | 459,277 | 201,684 | 897,930 |
Basic Shares | 182,851 | 183,271 | 182,602 | 182,005 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $627,241 | $285,143 | $117,005 | $89,792 |
Gross Profit | 392,660 | 140,929 | 51,642 | -223,554 |
EBITDA | -113,159 | -477,873 | -416,536 | -392,379 |
EBIT | -136,518 | -498,324 | -434,928 | -406,296 |
Net Income | -177,026 | -518,254 | -446,349 | -386,209 |
Net Change In Cash | 627,241 | 285,143 | 117,005 | 89,792 |
Free Cash Flow | -158,138 | -415,998 | -222,304 | -245,577 |
Cash | 286,749 | 1,277,713 | 786,031 | 688,938 |
Basic Shares | 182,851 | 176,082 | 159,041 | 140,851 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | $0.14 |
2024-09-30 | -$0.68 |
2024-06-30 | -$0.10 |
2024-03-31 | -$0.16 |
